AbbVie is a global biopharmaceutical company that employs approximately 26,700 people. Recent staffing activity shows about 2,100 hires versus roughly 1,200 departures, resulting in net headcount growth that supports ongoing research, commercial operations, and corporate infrastructure. This measured expansion reflects AbbVie’s focus on sustaining its drug portfolio and advancing pipeline programs across multiple therapeutic areas.
Engineering is AbbVie’s largest function with roughly 5,200 employees—close to one-fifth of overall staff—highlighting the company’s emphasis on process development and manufacturing excellence. Sales and Support follows at about 4,800 employees, underlining the scale required to bring therapies to market and service customers. Business Management, Healthcare, and Marketing & Product each exceed 2,700 employees and together account for a substantial share of the workforce, providing leadership, clinical expertise, and market enablement. Operations, Finance & Administration, Human Resources, Information Technology, and an assorted “Other” category round out the organization and ensure day-to-day business continuity.
AbbVie’s largest talent hub is the greater Chicago area, where roughly 5,400 employees are based. Additional U.S. clusters in Boston, New York, Irvine, San Francisco, Los Angeles, and Austin range from about 170 to 630 employees each, giving the company strong coverage across major life-science corridors. Internationally, Ireland hosts nearly 300 team members, while more than 18,500 employees work from other sites around the world, illustrating a geographically diverse footprint designed to reach patients and partners across multiple regions.